

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Isoamyl Nitrite
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Phase I
Sponsor : BARDA
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Study evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SIAN (stabilized isoamyl nitrite), a treatment being developed for known or suspected acute cyanide poisoning.
Product Name : SIAN
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 11, 2022
Lead Product(s) : Isoamyl Nitrite
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Phase I
Sponsor : BARDA
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Isoamyl Nitrite
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Phase I
Sponsor : Biomedical Advanced Research and Development Authority
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of SIAN Nasal Spray in Healthy Adults
Details : Stabilized (Isoamyl Nitrite) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Cyanide Poisoning.
Product Name : Stabilized
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 18, 2022
Lead Product(s) : Isoamyl Nitrite
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Phase I
Sponsor : Biomedical Advanced Research and Development Authority
Deal Size : Inapplicable
Deal Type : Inapplicable
